Chris Jewell
No más puestos en curso
Fortuna: - $ al 30/04/2024
Perfil
Chris Jewell is a Professor at the University of Maryland and the Chief Scientific Officer at Cartesian Therapeutics, Inc. He previously held the position of Chief Scientific Officer at Cartesian Therapeutics, Inc. in 2023.
He earned a doctorate degree from the University of Wisconsin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
-.--% | 18/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Chris Jewell
| Empresas | Cargo | Inicio |
|---|---|---|
| University of Maryland | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Chris Jewell.
| Empresas | Cargo | Fin |
|---|---|---|
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Director Técnico/Científico/I+D | 13/11/2023 |
Formación de Chris Jewell.
| University of Wisconsin | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Bolsa de valores
- Insiders
- Chris Jewell